Citius Oncology Net Tangible Assets

Citius Oncology (CTOR) currently reports a net tangible assets of $40M as of June 2026. That compares with $32M in the prior-year period — up 24.7% year over year. Use the charts on this page to explore Citius Oncology's net tangible assets history and peer comparisons.

Citius Oncology's net tangible assets increased from $32M to $40M — a 24.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Citius Oncology reported $40M in net tangible assets as of June 2026. That compares with $32M in the prior-year period — up 24.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $40M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Citius Oncology, and consider following CTOR for alerts when major investors trade the stock.